Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects

Cell Calcium

Volumn 46, Issue 3, 2009, Pages 154-162

  Lozovaya, Natalia ^a,b,d   Min, Rogier ^b,c   Tsintsadze, Vera ^d   Burnashev, Nail ^a,b  

^a INSERM   (France)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF BERN   (Switzerland)

^d BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

Anandamide; CB1R independent effects; Endocannabinoids; Voltage gated calcium channels

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; CANNABINOID; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; VOLTAGE GATED CALCIUM CHANNEL;

CALCIUM SIGNALING; CENTRAL NERVOUS SYSTEM; CHANNEL GATING; HUMAN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PURKINJE CELL; REGULATORY MECHANISM; REVIEW;

EID: 69249215137     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2009.07.007     Document Type: Review

References (95)

1. Berridge M.J. Elementary and global aspects of calcium signalling. J. Physiol. 499 Pt 2 (1997) 291-306
2. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., and Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 (1994) 686-691
3. Stella N., Schweitzer P., and Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388 (1997) 773-778
4. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
5. Irving A.J., Rae M.G., and Coutts A.A. Cannabinoids on the brain. Sci. World J. 2 (2002) 632-648
6. Adams I.B., Compton D.R., and Martin B.R. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther. 284 (1998) 1209-1217
7. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., Zimmer A., and Martin B.R. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75 (2000) 2434-2444
8. Fride E. Endocannabinoids in the central nervous system-an overview. Prostag. Leukotr. Essent. Fatty Acids 66 (2002) 221-233
9. Accorsi-Mendonca D., Almado C.E., Dagostin A.L., Machado B.H., and Leao R.M. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors. Brain Res. 1200 (2008) 1-9
10. Nemeth B., Ledent C., Freund T.F., and Hajos N. CB(1) receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN. Neuropharmacology 55 (2007) 212-222
11. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
12. Johnson D.E., Heald S.L., Dally R.D., and Janis R.A. Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding. Prostag. Leukotr. Essent. Fatty Acids 48 (1993) 429-437
13. Oz M. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol. Ther. 111 (2006) 114-144
14. 2+ channels. Annu. Rev. Cell Dev. Biol. 16 (2000) 521-555
15. Arikkath J., and Campbell K.P. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr. Opin. Neurobiol. 13 (2003) 298-307
16. Catterall W.A., Striessnig J., Snutch T.P., and Perez-Reyes E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol. Rev. 55 (2003) 579-581
17. Ertel E.A., Campbell K.P., Harpold M.M., Hofmann F., Mori Y., Perez-Reyes E., Schwartz A., Snutch T.P., Tanabe T., Birnbaumer L., Tsien R.W., and Catterall W.A. Nomenclature of voltage-gated calcium channels. Neuron 25 (2000) 533-535
18. Trimmer J.S., and Rhodes K.J. Localization of voltage-gated ion channels in mammalian brain. Annu. Rev. Physiol. 66 (2004) 477-519
19. Takahashi T., and Momiyama A. Different types of calcium channels mediate central synaptic transmission. Nature 366 (1993) 156-158
20. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 68 (2002) 247-286
21. Lenz R.A., Wagner J.J., and Alger B.E. N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J. Physiol. 512 Pt 1 (1998) 61-73
22. Wilson R.I., Kunos G., and Nicoll R.A. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31 (2001) 453-462
23. Huang C.C., Lo S.W., and Hsu K.S. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol. 532 (2001) 731-748
24. Liang Y.C., Huang C.C., Hsu K.S., and Takahashi T. Cannabinoid-induced presynaptic inhibition at the primary afferent trigeminal synapse of juvenile rat brainstem slices. J. Physiol. 555 (2004) 85-96
25. Caulfield M.P., and Brown D.A. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106 (1992) 231-232
26. Mackie K., and Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 3825-3829
27. Mackie K., Devane W.A., and Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44 (1993) 498-503
28. 2+ channels in a neuronal expression system. Mol. Pharmacol. 49 (1996) 707-714
29. Guo J., and Ikeda S.R. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol. Pharmacol. 65 (2004) 665-674
30. Shen M., and Thayer S.A. The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res. 783 (1998) 77-84
31. D'Amico M., Cannizzaro C., Preziosi P., and Martire M. Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus. Neurochem. Res. 29 (2004) 1553-1561
32. Hajos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
33. Kofalvi A., Rodrigues R.J., Ledent C., Mackie K., Vizi E.S., Cunha R.A., and Sperlagh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J. Neurosci. 25 (2005) 2874-2884
34. Matyas F., Yanovsky Y., Mackie K., Kelsch W., Misgeld U., and Freund T.F. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137 (2006) 337-361
35. Pistis M., Perra S., Pillolla G., Melis M., Gessa G.L., and Muntoni A.L. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 46 (2004) 115-125
36. 2+ channel mutant mice. J. Neurosci. 22 (2002) 4388-4398
37. Llinas R.R., Sugimori M., and Cherksey B. Voltage-dependent calcium conductances in mammalian neurons. The P channel. Ann. NY Acad. Sci. 560 (1989) 103-111
38. Brown S.P., Safo P.K., and Regehr W.G. Endocannabinoids inhibit transmission at granule cell to Purkinje cell synapses by modulating three types of presynaptic calcium channels. J. Neurosci. 24 (2004) 5623-5631
39. Mintz I.M., Sabatini B.L., and Regehr W.G. Calcium control of transmitter release at a cerebellar synapse. Neuron 15 (1995) 675-688
40. 2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse. J. Neurosci. 24 (2004) 5955-5965
41. Mackie K., Lai Y., Westenbroek R., and Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15 (1995) 6552-6561
42. Twitchell W., Brown S., and Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78 (1997) 43-50
43. Fisyunov A., Tsintsadze V., Min R., Burnashev N., and Lozovaya N. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons. J. Neurophysiol. 96 (2006) 1267-1277
44. Breivogel C.S., Griffin G., Di Marzo V., and Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol. 60 (2001) 155-163
45. Yoshida T., Fukaya M., Uchigashima M., Miura E., Kamiya H., Kano M., and Watanabe M. Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J. Neurosci. 26 (2006) 4740-4751
46. Hillman D., Chen S., Aung T.T., Cherksey B., Sugimori M., and Llinas R.R. Localization of P-type calcium channels in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7076-7080
47. Brenowitz S.D., Best A.R., and Regehr W.G. Sustained elevation of dendritic calcium evokes widespread endocannabinoid release and suppression of synapses onto cerebellar Purkinje cells. J. Neurosci. 26 (2006) 6841-6850
48. Womack M.D., Chevez C., and Khodakhah K. Calcium-activated potassium channels are selectively coupled to P/Q-type calcium channels in cerebellar Purkinje neurons. J. Neurosci. 24 (2004) 8818-8822
49. Womack M.D., and Khodakhah K. Dendritic control of spontaneous bursting in cerebellar Purkinje cells. J. Neurosci. 24 (2004) 3511-3521
50. 2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature 399 (1999) 155-159
51. Nam S.C., and Hockberger P.E. Analysis of spontaneous electrical activity in cerebellar Purkinje cells acutely isolated from postnatal rats. J. Neurobiol. 33 (1997) 18-32
52. Raman I.M., and Bean B.P. Ionic currents underlying spontaneous action potentials in isolated cerebellar Purkinje neurons. J. Neurosci. 19 (1999) 1663-1674
53. Womack M., and Khodakhah K. Active contribution of dendrites to the tonic and trimodal patterns of activity in cerebellar Purkinje neurons. J. Neurosci. 22 (2002) 10603-10612
54. Johnston D., Christie B.R., Frick A., Gray R., Hoffman D.A., Schexnayder L.K., Watanabe S., and Yuan L.L. Active dendrites, potassium channels and synaptic plasticity. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 358 (2003) 667-674
55. Snutch T.P., Sutton K.G., and Zamponi G.W. Voltage-dependent calcium channels-beyond dihydropyridine antagonists. Curr. Opin. Pharmacol. 1 (2001) 11-16
56. 2+ channel current. Am. J. Physiol. 276 (1999) H2085-H2093
57. 2+ channel. Eur. J. Pharmacol. 296 (1996) 347-350
58. Oz M., Tchugunova Y.B., and Dunn S.M. Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes. Eur. J. Pharmacol. 404 (2000) 13-20
59. Oz M., Tchugunova Y., and Dinc M. Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids. Eur. J. Pharmacol. 502 (2004) 47-58
60. Yunker A.M., Sharp A.H., Sundarraj S., Ranganathan V., Copeland T.D., and McEnery M.W. Immunological characterization of T-type voltage-dependent calcium channel CaV3.1 (alpha 1G) and CaV3.3 (alpha 1I) isoforms reveal differences in their localization, expression, and neural development. Neuroscience 117 (2003) 321-335
61. Chemin J., Monteil A., Perez-Reyes E., Nargeot J., and Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J. 20 (2001) 7033-7040
62. Huguenard J.R. Low-threshold calcium currents in central nervous system neurons. Annu. Rev. Physiol. 58 (1996) 329-348
63. Steriade M., McCormick D.A., and Sejnowski T.J. Thalamocortical oscillations in the sleeping and aroused brain. Science 262 (1993) 679-685
64. Ross H.R., Napier I., and Connor M. Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol. J. Biol. Chem. 283 (2008) 16124-16134
65. Yokoyama C.T., Westenbroek R.E., Hell J.W., Soong T.W., Snutch T.P., and Catterall W.A. Biochemical properties and subcellular distribution of the neuronal class E calcium channel alpha 1 subunit. J. Neurosci. 15 (1995) 6419-6432
66. 2+ currents evoke transmitter release at a rat central synapse. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 4720-4725
67. 2+ channels. Neuron 39 (2003) 483-496
68. Endoh T. Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitarius. Br. J. Pharmacol. 147 (2006) 391-401
69. Martin B.R. Cellular effects of cannabinoids. Pharmacol. Rev. 38 (1986) 45-74
70. Leaf A., Xiao Y.F., and Kang J.X. Interactions of n-3 fatty acids with ion channels in excitable tissues. Prostag. Leukotr. Essent. Fatty Acids 67 (2002) 113-120
71. Lee A.G. Lipid-protein interactions in biological membranes: a structural perspective. Biochim. Biophys. Acta 1612 (2003) 1-40
72. Tillman T.S., and Cascio M. Effects of membrane lipids on ion channel structure and function. Cell Biochem. Biophys. 38 (2003) 161-190
73. Chemin J., Nargeot J., and Lory P. Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels. J. Biol. Chem. 282 (2007) 2314-2323
74. Antollini S.S., and Barrantes F.J. Unique effects of different fatty acid species on the physical properties of the torpedo acetylcholine receptor membrane. J. Biol. Chem. 277 (2002) 1249-1254
75. Garcia M.L. Ion channels: gate expectations. Nature 430 (2004) 153-155
76. Barrantes F.J. Lipid matters: nicotinic acetylcholine receptor-lipid interactions (Review). Mol. Membr. Biol. 19 (2002) 277-284
77. Tian X., Guo J., Yao F., Yang D.P., and Makriyannis A. The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer. J. Biol. Chem. 280 (2005) 29788-29795
78. Schmidt D., Jiang Q.X., and MacKinnon R. Phospholipids and the origin of cationic gating charges in voltage sensors. Nature 444 (2006) 775-779
79. Mateo C.R., Villalaín J.G.J., and González Ros J.M. Protein-Lipid Interactions-New Approaches and Emerging Concepts (2006), Springer-Velag, Berlin, Heidelberg
80. Xiao Y.F., Ke Q., Wang S.Y., Auktor K., Yang Y., Wang G.K., Morgan J.P., and Leaf A. Single point mutations affect fatty acid block of human myocardial sodium channel alpha subunit Na+ channels. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3606-3611
81. 2+ channel alpha1G. J. Gen. Physiol. 124 (2004) 225-238
82. Hockerman G.H., Peterson B.Z., Johnson B.D., and Catterall W.A. Molecular determinants of drug binding and action on L-type calcium channels. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 361-396
83. Hockerman G.H., Johnson B.D., Scheuer T., and Catterall W.A. Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels. J. Biol. Chem. 270 (1995) 22119-22122
84. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592
85. Van der Stelt M., and Di Marzo V. Anandamide as an intracellular messenger regulating ion channel activity. Prostag. Other Lipid Mediators 77 (2005) 111-122
86. Roth S.H., and Williams P.J. The non-specific membrane binding properties of delta9-tetrahydrocannabinol and the effects of various solubilizers. J. Pharm. Pharmacol. 31 (1979) 224-230
87. Chakrabarti A., Ekuta J.E., and Onaivi E.S. Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. Brain Res. Bull. 45 (1998) 67-74
88. Chaperon F., and Thiebot M.H. Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 13 (1999) 243-281
89. Compton D.R., and Martin B.R. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J. Pharmacol. Exp. Ther. 283 (1997) 1138-1143
90. Crawley J.N., Corwin R.L., Robinson J.K., Felder C.C., Devane W.A., and Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav. 46 (1993) 967-972
91. Lichtman A.H., Wiley J.L., LaVecchia K.L., Neviaser S.T., Arthur D.B., Wilson D.M., and Martin B.R. Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. Eur. J. Pharmacol. 357 (1998) 139-148
92. Baskfield C.Y., Martin B.R., and Wiley J.L. Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice. J. Pharmacol. Exp. Ther. 309 (2004) 86-91
93. Coomber B., O'Donoghue M.F., and Mason R. Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid. Synapse 62 (2008) 746-755
94. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., Palmery M., Cuomo V., and Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9 (2003) 76-81
95. Pellegrini-Giampietro D.E., Mannaioni G., and Bagetta G. Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death. FEBS J. 276 (2009) 2-12